Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-078840·ADAR1 Capital Management, LLC
Schedule 13G ownership disclosure
Kiora Pharmaceuticals Inc
Common Stock, par value $0.01 per share · CUSIP: 49721T507
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ADAR1 Capital Management, LLC
Shares: 362,527.00 · Class: 9.9%
- ADAR1 Capital Management GP, LLC
Shares: 365,179.00 · Class: 9.9%
- Daniel Schneeberger
Shares: 362,527.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-078840
- Form type
- SCHEDULE 13G/A
- Filer
- ADAR1 Capital Management, LLC
- CIK
- CIK 1940272
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership